Efficacy of Vyepti highlighted by new clinical trial results in severe migraine
New RESOLUTION trial results show Vyepti® (eptinezumab) significantly reduces monthly migraine days (MMDs) in patients with chronic migraine and medication-overuse headache, with rapid benefits observed.
© Copyright 2024. All Rights Reserved by MedPath